June Bray's most recent trade in Quince Therapeutics Inc was a trade of 27,000 Director Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 4, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Quince Therapeutics Inc | June Bray | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2025 | 27,000 | 27,000 | - | - | Director Stock Option (Right to Buy) | |
| Quince Therapeutics Inc | June Bray | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 30,282 | 30,282 | - | - | Director Stock Option (right to buy) | |
| BioXcel Therapeutics Inc | June Bray | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2024 | 17,000 | 17,000 | - | - | Stock Option (Right to Buy) | |
| Quince Therapeutics Inc | June Bray | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 27,000 | 27,000 | - | - | Employee Stock Option (right to buy) | |
| BioXcel Therapeutics Inc | June Bray | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2023 | 17,000 | 17,000 | - | - | Stock Option (Right to Buy) | |
| Quince Therapeutics Inc | June Bray | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2023 | 27,000 | 27,000 | - | - | Stock Option (right to buy) | |
| Quince Therapeutics Inc | June Bray | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 54,000 | 54,000 | - | - | Stock Option (right to buy) | |
| BioXcel Therapeutics Inc | June Bray | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2022 | 17,000 | 17,000 | - | - | Stock Option (Right to Buy) | |
| BioXcel Therapeutics Inc | June Bray | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2021 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| BioXcel Therapeutics Inc | June Bray | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 4,167 | 4,167 | - | - | Stock Option (Right to Buy) |